C. Borleffs

发表

Longitudinal mechanics of the periinfarct zone and ventricular tachycardia inducibility in patients with chronic ischemic cardiomyopathy.

Katja Zeppenfeld, Jeroen J. Bax, Martin J Schalij, 2010, American heart journal.

Optimal left ventricular lead position assessed with phase analysis on gated myocardial perfusion SPECT

Jeroen J. Bax, Martin J. Schalij, M. Schalij, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

Influence of the vectorcardiogram synthesis matrix on the power of the electrocardiogram-derived spatial QRS-T angle to predict arrhythmias in patients with ischemic heart disease and systolic left ventricular dysfunction.

SumChe Man, Martin J Schalij, Cees A Swenne, 2011, Journal of electrocardiology.

Relative Merits of Left Ventricular Dyssynchrony, Left Ventricular Lead Position, and Myocardial Scar to Predict Long-Term Survival of Ischemic Heart Failure Patients Undergoing Cardiac Resynchronization Therapy

Eric Boersma, Matteo Bertini, E. Holman, 2011, Circulation.

QRS fusion complex analysis using wave interference to predict reverse remodeling during cardiac resynchronization therapy.

Jeroen J. Bax, M. Schalij, M. Sweeney, 2014, Heart rhythm.

Martin J Schalij, M. Schalij, L. van Erven, 2011, Journal of the American College of Cardiology.

Analysis of Ventricular Activation Using Surface Electrocardiography to Predict Left Ventricular Reverse Volumetric Remodeling During Cardiac Resynchronization Therapy

Jeroen J. Bax, M. Schalij, M. Sweeney, 2010, Circulation.

Cost‐Effectiveness of Primary Prevention Implantable Cardioverter Defibrillator Treatment: Data from a Large Clinical Registry

M. Schalij, C. Borleffs, J. Thijssen, 2014, Pacing and clinical electrophysiology : PACE.

Structured care for patients after acute myocardial infarction: sudden cardiac death prevention--data from the Leiden MISSION! AMI study.

Jeroen J. Bax, Bas L van der Hoeven, M. Schalij, 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Biventricular pacing-induced acute response in baroreflex sensitivity has predictive value for midterm response to cardiac resynchronization therapy.

Jeroen J. Bax, M. Schalij, E. E. van der Wall, 2009, American journal of physiology. Heart and circulatory physiology.

The clinical course of patients with implantable cardioverter-defibrillators: Extended experience on clinical outcome, device replacements, and device-related complications.

M. Schalij, S. Cannegieter, L. van Erven, 2015, Heart rhythm.

Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy

M. Schalij, E. E. van der Wall, C. Borleffs, 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Primary Prevention Implantable Cardioverter Defibrillator Recipients: The Need for Defibrillator Back‐Up After an Event‐Free First Battery Service‐Life

M. Schalij, L. van Erven, C. Borleffs, 2011, Journal of cardiovascular electrophysiology.

Implantable cardioverter defibrillator treatment : benefits and pitfalls in the currently indicated population

C. Borleffs, 2010 .

Risk of Failure of Transvenous Implantable Cardioverter-Defibrillator Leads

Jeroen J. Bax, M. Schalij, E. E. van der Wall, 2008, Circulation. Arrhythmia and electrophysiology.

Recurrence of ventricular arrhythmias in ischaemic secondary prevention implantable cardioverter defibrillator recipients: long-term follow-up of the Leiden out-of-hospital cardiac arrest study (LOHCAT).

Jeroen J. Bax, M. Schalij, K. Zeppenfeld, 2009, European heart journal.

Clinical importance of new-onset atrial fibrillation after cardiac resynchronization therapy.

Jeroen J. Bax, M. Schalij, L. van Erven, 2009, Heart rhythm.

Early Reperfusion Therapy Affects Inducibility, Cycle Length, and Occurrence of Ventricular Tachycardia Late After Myocardial Infarction

Jeroen J. Bax, M. Schalij, K. Zeppenfeld, 2011, Circulation. Arrhythmia and electrophysiology.

The right timing for the left lead: Now or later?

L. van Erven, C. Borleffs, J. Thijssen, 2017, Heart rhythm.

Cardiac resynchronization therapy in patients with ischemic versus non-ischemic heart failure: Differential effect of optimizing interventricular pacing interval.

Jeroen J. Bax, E. Holman, M. Schalij, 2009, American heart journal.

Implantable Cardioverter-Defibrillators Have Reduced the Incidence of Resuscitation for Out-of-Hospital Cardiac Arrest Caused by Lethal Arrhythmias

H. Tan, R. Koster, J. R. de Groot, 2012, Circulation.

Nationwide claims data validated for quality assessments in acute myocardial infarction in the Netherlands

M. Schalij, A. Mosterd, V. Umans, 2017, Netherlands Heart Journal.

Coronary heart disease Time course of global left ventricular strain after acute myocardial infarction

Jeroen J. Bax, E. Holman, M. Schalij, 2010 .

Gender-specific differences in clinical outcome of primary prevention implantable cardioverter defibrillator recipients

M. Schalij, E. T. van der Velde, L. van Erven, 2013, Heart.

Driving restrictions after implantable cardioverter defibrillator implantation: an evidence-based approach

Jeroen J. Bax, M. Schalij, E. T. van der Velde, 2011, European heart journal.

Primary prevention implantable cardioverter-defibrillator implantation in elderly patients: is it justified to withhold treatment?

M. Schalij, L. van Erven, C. Borleffs, 2014, Expert review of cardiovascular therapy.

Update on Small‐Diameter Implantable Cardioverter‐Defibrillator Leads Performance

M. Schalij, E. E. van der Wall, E. T. van der Velde, 2012, Pacing and clinical electrophysiology : PACE.

Right ventricular stimulation threshold at ICD implant predicts device therapy in primary prevention patients with ischaemic heart disease.

M. Schalij, K. Zeppenfeld, L. van Erven, 2010, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Requirement for coronary sinus lead interventions and effectiveness of endovascular replacement during long-term follow-up after implantation of a resynchronization device.

M. Schalij, L. van Erven, C. Borleffs, 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Comparison of time course of response to cardiac resynchronization therapy in patients with ischemic versus nonischemic cardiomyopathy.

Jeroen J. Bax, E. Holman, M. Schalij, 2009, The American journal of cardiology.

Super‐responders to cardiac resynchronization therapy remain at risk for ventricular arrhythmias and benefit from defibrillator treatment

M. Schalij, E. T. van der Velde, L. van Erven, 2014, European journal of heart failure.

Cardiac device infections are associated with a significant mortality risk.

M. Schalij, S. Cannegieter, L. van Erven, 2012, Heart rhythm.

Effect of cardiac resynchronization therapy on subendo- and subepicardial left ventricular twist mechanics and relation to favorable outcome.

Jeroen J. Bax, G. Boriani, M. Schalij, 2010, The American journal of cardiology.

PACING-INDUCED ACUTE RESPONSE IN BAROREFLEX SENSITIVITY HAS PREDICTIVE VALUE FOR MID-TERM RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY

M. Schalij, S. Man, C. Borleffs, 2009 .

Long-term follow-up of primary and secondary prevention implantable cardioverter deﬁbrillator patients

Jeroen J. Bax, M. Schalij, S. Cannegieter, 2011 .

PREDICTION OF NON-BENEFIT FROM IMPLANTABLE CARDIOVERTER DEFIBRILLATOR TREATMENT IN PRIMARY PREVENTION PATIENTS WITH ISCHEMIC HEART DISEASE

H. Putter, M. Schalij, J. Bom, 2011 .

Clinical implementation of guidelines for cardioverter defibrillator implantation: lost in translation?

A. Wilde, A. Mosterd, E. Wever, 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial

P. Ponikowski, J. Wranicz, H. Schirmer, 2022, Nature Medicine.

Chapter 13 left ventricular longitudinal strain is related to left ventricular myocardial scar tissue assessed with contrast-enhanced magnetic resonance imaging and predicts response to cardiac resynchronization therapy

Jeroen J. Bax, H. Lamb, A. Roos, 2010 .

The year of transparency: measuring quality of cardiac care

M. Schalij, B. D. de Mol, M. D. de Bruijne, 2015, Netherlands Heart Journal.

Rationale and design of the CAREFUL study

P. Doevendans, A. Wilde, M. Bots, 2010, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.

Short-term career perspectives of young cardiologists in the Netherlands

B. Zwart, R. Scherptong, C. Borleffs, 2017, Netherlands Heart Journal.

Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction.

Akshay S. Desai, D. DeMets, A. Desai, 2022, The New England journal of medicine.

The jugular approach for leadless pacing: A novel and safe alternative

H. Ramanna, Vincent J.H.M. Driel, C. Borleffs, 2022, Pacing and clinical electrophysiology : PACE.

Substrate Assessment: Echocardiography, MRI, and CCT

Jeroen J. Bax, M. Schalij, M. Bertini, 2012 .

Leadless pacing: Going for the jugular

H. Ramanna, V. V. van Driel, C. Borleffs, 2019, Pacing and clinical electrophysiology : PACE.

Incidence and Clinical Significance of New-Onset Device-Detected Atrial Tachyarrhythmia: A Meta-Analysis

Jagmeet P. Singh, A. Waldo, D. Hayes, 2016, Circulation. Arrhythmia and electrophysiology.

Prognostic importance of atrial fibrillation in implantable cardioverter-defibrillator patients.

Jeroen J. Bax, M. Schalij, E. T. van der Velde, 2010, Journal of the American College of Cardiology.

The mode of death in implantable cardioverter-defibrillator and cardiac resynchronization therapy with defibrillator patients: results from routine clinical practice.

H. Putter, M. Schalij, E. T. van der Velde, 2012, Heart rhythm.

Age and gender differences in medical adherence after myocardial infarction: Women do not receive optimal treatment – The Netherlands claims database

M. Schalij, C. Borleffs, D. Eindhoven, 2018, European journal of preventive cardiology.

Primary prevention implantable cardioverter–defibrillator treatment: how to identify patients most likely to benefit?

M. Schalij, C. Borleffs, J. Thijssen, 2012, Expert review of cardiovascular therapy.

Time course of global left ventricular strain after acute myocardial infarction.

Jeroen J. Bax, E. Holman, M. Schalij, 2010, European heart journal.

Prognostic Impact of Implementation of QRS Characteristics in the Seattle Heart Failure Model in ICD and CRT‐D Recipients

M. Schalij, L. van Erven, W. Levy, 2016, Pacing and clinical electrophysiology : PACE.

Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart disease.

Jeroen J. Bax, H. Putter, M. Schalij, 2009, European heart journal.

Association of intraventricular mechanical dyssynchrony with response to cardiac resynchronization therapy in heart failure patients with a narrow QRS complex

Jeroen J. Bax, John Gorcsan, Martin J. Schalij, 2010, European heart journal.

Impact of clinical and echocardiographic response to cardiac resynchronization therapy on long-term survival.

Jeroen J. Bax, M. Schalij, M. Bertini, 2013, European heart journal cardiovascular Imaging.

IMPACT OF CLINICAL AND ECHOCARDIOGRAPHIC RESPONSE TO CARDIAC RESYNCHRONIZATION THERAPY ON LONG-TERM SURVIVAL

Jeroen J. Bax, M. Schalij, M. Bertini, 2011 .

Prediction of Cardiac Resynchronization Therapy ResponseCLINICAL PERSPECTIVE

Jeroen J. Bax, G. Boriani, M. Schalij, 2010 .

Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.

Jeroen J. Bax, M. Schalij, E. Boersma, 2011, Journal of the American College of Cardiology.

Long-term prognosis after cardiac resynchronization therapy is related to the extent of left ventricular reverse remodeling at midterm follow-up.

Jeroen J. Bax, Eric Boersma, Martin J Schalij, 2009, Journal of the American College of Cardiology.

Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy.

Jeroen J. Bax, M. Schalij, M. Biffi, 2010, The American journal of cardiology.

Trans-venous lead removal without the use of extraction sheaths, results of >250 removal procedures.

Martin J Schalij, Marianne Bootsma, M. Schalij, 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality.

Jeroen J. Bax, T. Stijnen, M. Schalij, 2011, Journal of the American College of Cardiology.

Prognostic importance of strain and strain rate after acute myocardial infarction.

Jeroen J. Bax, Eric Boersma, Martin J Schalij, 2010, European heart journal.

Prediction of atrial fibrillation in patients with an implantable cardioverter‐defibrillator and heart failure

Jeroen J. Bax, G. Boriani, M. Schalij, 2010, European journal of heart failure.

Cardiogenetic screening of first-degree relatives after sudden cardiac death in the young: a population-based approach.

A. Wilde, M. Bots, A. Mosterd, 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

A randomised comparison of the effect of haemodynamic monitoring with CardioMEMS in addition to standard care on quality of life and hospitalisations in patients with chronic heart failure

M. Rienstra, P. van Baal, R. D. de Boer, 2019, Netherlands Heart Journal.

Cardiac sympathetic denervation assessed with 123-iodine metaiodobenzylguanidine imaging predicts ventricular arrhythmias in implantable cardioverter-defibrillator patients.

Jeroen J. Bax, M. Henneman, M. Schalij, 2010, Journal of the American College of Cardiology.

Effect of cardiac resynchronization therapy in patients with New York Heart Association functional class IV heart failure.

Jeroen J. Bax, M. Schalij, M. Bertini, 2010, The American journal of cardiology.

Comparison of long-term survival of men versus women with heart failure treated with cardiac resynchronization therapy.

Jeroen J. Bax, M. Schalij, E. E. van der Wall, 2011, The American journal of cardiology.

Long-term follow-up of primary and secondary prevention implantable cardioverter defibrillator patients.

Jeroen J. Bax, Martin J Schalij, M. Schalij, 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Cardiac Resynchronization Therapy as a Therapeutic Option in Patients With Moderate-Severe Functional Mitral Regurgitation and High Operative Risk

Jeroen J. Bax, M. Schalij, V. Delgado, 2011, Circulation.

Implementation of Lead Safety Recommendations

Jeroen J. Bax, M. Schalij, E. T. van der Velde, 2010, Pacing and clinical electrophysiology : PACE.

Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score

Jeroen J. Bax, H. Putter, M. Schalij, 2012, Heart.

Effects of cardiac resynchronization therapy on left ventricular twist.

G. Boriani, E. Holman, M. Schalij, 2008, Journal of the American College of Cardiology.

Application and comparison of the FADES, MADIT, and SHFM-D risk models for risk stratification of prophylactic implantable cardioverter-defibrillator treatment

M. Schalij, S. Cannegieter, L. van Erven, 2017, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer.

SumChe Man, Martin J Schalij, M. Schalij, 2012, Heart rhythm.

Recurrent Implantable Cardioverter‐Defibrillator Replacement Is Associated with an Increasing Risk of Pocket‐Related Complications

Jeroen J. Bax, Martin J Schalij, M. Schalij, 2010, Pacing and clinical electrophysiology : PACE.

Moderate-Severe Functional Mitral Regurgitation and High Operative Risk Cardiac Resynchronization Therapy as a Therapeutic Option in Patients With

M. Schalij, V. Delgado, N. Marsan, 2011 .

Effect of cardiac resynchronization therapy on cerebral blood flow.

Jeroen J. Bax, M. Schalij, M. Bertini, 2010, The American journal of cardiology.

Impaired renal function is associated with echocardiographic nonresponse and poor prognosis after cardiac resynchronization therapy.

Jeroen J. Bax, M. Schalij, E. E. van der Wall, 2011, Journal of the American College of Cardiology.

Value of tissue Doppler echocardiography in predicting response to cardiac resynchronization therapy in patients with heart failure.

Jeroen J. Bax, Martin J Schalij, Eduard R Holman, 2010, The American journal of cardiology.

Association of Dapagliflozin vs Placebo With Individual Kansas City Cardiomyopathy Questionnaire Components in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Secondary Analysis of the DELIVER Trial.

Akshay S. Desai, J. McMurray, P. Jhund, 2023, JAMA cardiology.

Site of latest activation in patients eligible for cardiac resynchronization therapy: patterns of dyssynchrony among different QRS configurations and impact of heart failure etiology.

Jeroen J. Bax, M. Schalij, E. E. van der Wall, 2011, American heart journal.

A focus on female gender in the treatment of acute coronary syndrome patients; determining differences in the type, nature and preventability of adverse event rates by means of medical record review

M. Schalij, C. Brouwers, C. Borleffs, 2019 .

Predicting Ventricular Arrhythmias in Patients With Ischemic Heart Disease: Clinical Application of the ECG-Derived QRS-T Angle

Jeroen J. Bax, Martin J Schalij, Cees A Swenne, 2009, Circulation. Arrhythmia and electrophysiology.

Effect of biventricular pacing on diastolic dyssynchrony.

Jeroen J. Bax, E. Holman, M. Schalij, 2010, Journal of the American College of Cardiology.

Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome.

Jeroen J. Bax, M. Schalij, E. E. van der Wall, 2010, European heart journal.

Predictive power of T-wave alternans and of ventricular gradient hysteresis for the occurrence of ventricular arrhythmias in primary prevention cardioverter-defibrillator patients.

Laura Burattini, Roberto Burattini, Sumche Man, 2011, Journal of electrocardiology.

Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial

Matt Post, M. Rienstra, E. Boersma, 2023, The Lancet.

Prophylactic implantable cardioverter-defibrillator treatment in the elderly: therapy, adverse events, and survival gain.

Jeroen J. Bax, M. Schalij, S. Cannegieter, 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.